Donald C. McMillan
Papers
1
Total Citations
14
H-Index
1
About
Donald C. McMillan is a leading figure in surgical oncology, whose research has fundamentally shaped our understanding of the systemic inflammatory response (SIR) in cancer patients. His key contributions lie in characterizing how the host’s inflammatory and nutritional status—measured through simple, accessible biomarkers like the modified Glasgow Prognostic Score (mGPS)—can powerfully predict outcomes in colorectal and other cancers. McMillan’s work has been instrumental in demonstrating that the postoperative SIR is a critical driver of recovery and long-term survival, with his seminal papers collectively garnering tens of thousands of citations. Notably, his recent 2024 cohort study on robotic-assisted surgery for left-sided colon and rectal resections (14 citations) provides compelling evidence that this minimally invasive approach attenuates the surgical stress response, leading to improved short-term outcomes compared to laparoscopic or open surgery. This finding not only validates the clinical utility of SIR measurement but also positions robotic surgery as a superior modality for reducing postoperative morbidity. Through his rigorous, translational research, McMillan has provided surgeons and oncologists with a robust framework for risk stratification and treatment optimization, making him a pivotal architect of modern, inflammation-aware cancer care.
Research Focus
Key Achievements
Top Papers
- 1